OBJECTIVE: The purpose of our study was to analyze the efficacy, side effects, and short-term complications of saline-enhanced percutaneous radiofrequency ablation performed under sonographic guidance in a series of cirrhotic @entity1 with @entity157 . SUBJECTS AND METHODS. Between September 2000 and June 2002, 84 @entity1 (55 @entity1 and 29 @entity1 ) with @entity82 who ranged in age from 48 to 74 years (mean age, 64 years) and who had 95 @entity157 (seven @entity1 had two @entity5 and two @entity1 had three @entity5 ) were treated with high frequency-induced thermotherapy. The diameters of the @entity5 ranged from 1.5 to 8.5 cm (mean, 3.6 cm). The efficacy of radiofrequency ablation was evaluated with triphasic contrast-enhanced CT performed 4 weeks after the procedure. RESULTS: Posttreatment CT showed complete @entity39 in 73 (77%) of 95 @entity157 in 62 @entity1 . Complete @entity39 based on @entity5 size was seen in 40 (95%) of 42 @entity5 with diameters equal to or smaller than 3 cm, 32 (71%) of 45 @entity5 with diameters between 3.1 and 5.0 cm, and one (12%) of @entity5 with diameters larger than 5.0 cm. Twenty-two @entity157 showed incomplete @entity39 . None of the @entity1 experienced major complications. Four @entity1 were lost to follow-up. The length of the follow-up period ranged from 4 to 22 months (mean, 10 months). One @entity1 died 8 months after the radiofrequency ablation treatment. All the remaining @entity1 are still alive. During the follow-up period, eight (10%) of 80 @entity1 showed a local recurrence on sonography and CT. CONCLUSION: Our experience suggests that percutaneous radiofrequency ablation of @entity157 with high frequency-induced thermotherapy is safe and effective in the treatment of @entity157 equal to or smaller than 3 cm, fairly effective for @entity157 between 3 and 5 cm, and ineffective for @entity5 larger than 5 cm.

Percutaneous sonographically guided saline-enhanced radiofrequency ablation of XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient', 'men'] @entity82 :: ('MESH:D005355', 'Disease') :: ['cirrhosis'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrosis'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'eight tumors', 'tumors'] @entity157 :: ('MESH:D006528', 'Disease') :: ['hepatocellular carcinoma', 'hepatocellular carcinomas']
@entity157 :: (MESH:D006528,Disease) :: ['hepatocellular carcinoma']
